Posted by Michael Wonder on 23 Jun 2023
Changes to PBS eligibility criteria for Paxlovid
23 June 2023 - In an out of session consideration, the PBAC has recommended changes to the circumstances under which nirmatrelvir and ritonavir (Paxlovid) is available on the PBS.
At an out of session meeting held between March and June 2023, the PBAC recommended expanding the PBS patient eligibility criteria for nirmatrelvir and ritonavir to include patients aged 50-59 years with mild to moderate COVID-19 and one additional risk factor.
In December 2022, the PBAC recommended expanding the PBS patient eligibility for nirmatrelvir and ritonavir to include patients aged 60-69 years with mild to moderate COVID-19 and one additional risk factor.
